MedPath

Effects of different administration times of tablets with a combination of telmisartan and amlodipine on CKD patients with hypertensio

Not Applicable
Conditions
CKD with hypertension
Registration Number
JPRN-UMIN000011531
Lead Sponsor
Department of General Internal Medicine, Saitama Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients allergic to CCB or ARB 2)Patients with liver dysfunction 3)Patients with pregnancy, or with its possibility

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath